The Next Generation Biotech Media
The 39th J.P. Morgan Healthcare Conference witnessed several important announcements from healthcare giants and pharma behemoths. Some of them discussed their efforts to fight against the pandemic, and others revealed …
Read More
It has been a year to remember. A year that has reminded us of the dangers of negligence and how little lapses can trigger a global crisis of massive proportions. …
Read More
Just when nations worldwide would have anticipated ending the year on a high with the recently approved COVID-19 vaccines, a new fast-spreading coronavirus variant, named B.1.1.7 (VUI-202012/01) has debuted on …
Read More
November 18th, 2020 – Pharma giant Pfizer and BioNTech announced today that their mRNA vaccine candidate BNT162b2 shows 95% efficacy and has met all of the primary efficacy endpoints in …
Read More
Moderna is out with interim results for its coronavirus vaccines, saying that it is 94.5% effective in preventing COVID-19, a bit more efficacious than Pfizer’s mRNA-based vaccine. However, one must …
Read More
Renal cell carcinoma (RCC) is the most common type of kidney cancer, which is twice as common in men as in women. In the year 2020 alone, it is estimated …
Read More
On November 11th, Pfizer announced the results for their Phase 3 JADE REGIMEN study, which aimed to determine the efficacy of Abrocitinib in patients with moderate to acute atopic dermatitis …
Read More
Prostate cancer is the most commonly seen male urology-related cancers in China and the second most common cancer in men worldwide. Amongst all other types of prostate cancers, castration-resistant prostate …
Read More
In a major breakthrough in the COVID-19 vaccine race, Pfizer and BioNtech have announced that their COVID-19 vaccine candidate BNT162b2 has performed exceedingly well in Phase 3 clinical trial as …
Read More
Ankylosing Spondylitis (AS) is a chronic, inflammatory disease that causes enthesitis or inflammation where the tendons, ligaments, and bones meet. This debilitating condition affects approximately 1% of the US population, …
Read More